OSILODROSTAT

OSILODROSTAT (14714K)

osilodrostat 1 mg tablet, 60
14714K
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Endogenous Cushing's syndrome
Treatment phase: Initial treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 60 # of repeats: 6 DPMQ: $2,562.93 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Isturisa

OSILODROSTAT (14723X)

osilodrostat 1 mg tablet, 60
14723X
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Endogenous Cushing's syndrome
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 60 # of repeats: 5 DPMQ: $2,562.93 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Isturisa

OSILODROSTAT (14724Y)

osilodrostat 5 mg tablet, 60
14724Y
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Endogenous Cushing's syndrome
Treatment phase: Initial treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 60 # of repeats: 6 DPMQ: $9,822.93 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Isturisa

OSILODROSTAT (14729F)

osilodrostat 5 mg tablet, 60
14729F
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Endogenous Cushing's syndrome
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 60 # of repeats: 5 DPMQ: $9,822.93 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Isturisa